Veraxa Biotech AG - Post de-SPAC (VRXA) Payables (2024 - 2025)
Veraxa Biotech AG - Post de-SPAC's Payables was $2.99 million in the quarter ended Dec 31, 2025, up 436.4% from $557,683 a year earlier.
Powered by 
Analysis
Veraxa Biotech AG - Post de-SPAC (VRXA) Payables (2024 - 2025) Analysis & Trends
As of Dec 31, 2025, Payables at Veraxa Biotech AG - Post de-SPAC came in at $2.88 million, up 419.3% from the prior year.
- In earlier years, Payables was $555,328 in the year ended Dec 31, 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 18.17 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 5.96 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 7.03 Bn |
| 10 | Veraxa Biotech AG - Post de-SPAC | 14.47 Mn | 10.90 Mn | - | 3.02 Mn |
API Access
Veraxa Biotech AG - Post de-SPAC Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=VRXA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "VRXA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=VRXA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();